JuggerStitch for Meniscus Tear Repair

This study is testing the JuggerStitch Meniscal Repair Device, which is used to fix tears in the meniscus (cartilage in your knee). It's a follow-up study to confirm the device's safety and how well it works after it's been approved for use. We are looking for 104 participants who are at least 18 years old and have a meniscus tear that can be repaired. The main goal is to see if patients avoid needing another surgery for their meniscus tear one year after using the JuggerStitch device. The study's current status is unclear.

Study design
This is an interventional study planning to enroll 104 participants. It is a post-market follow-up study.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year to measure clinical success.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04228367

JuggerStitch Post Market Clinical Follow-up Study

Recruiting
NAAges 18+InterventionalTreatment
Zimmer Biomet
~104 participants
Updated 2025-11-12 on ClinicalTrials.gov
What's tested:JuggerStitch Meniscal Repair Device

At a glance

Recruiting sites
4 of 6 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical Success
Measured over 1 year
Meniscus Tear, Tibial
Meniscus Lesion

NCT04228367

Where you'd take part

This study runs at 6 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Ichihara Hospital

    Tsukuba, Ibaraki, Japanno site contact published

    Recruiting

  • Medizinische Fakultät der Otto-von-Guericke-Universität Magdeburg

    Magdeburg, Germanyno site contact published

    Recruiting

  • Ramsay General de Sante - Hôpital Privé Jean Mermoz - Centre Orthopédique Santy

    Lyon, Franceno site contact published

    Recruiting

  • Tokyo Medical and Dental University Hospital of Medicine

    Tokyo, Japanno site contact published

    Recruiting

  • OrthoCarolina

    Charlotte, North Carolinano site contact published

    Active, not recruiting

  • OrthoVirginia, Inc.

    Richmond, Virginiano site contact published

    Active, not recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • Nesma Bayrich, DDS · STUDY_CHAIR · Zimmer Biomet
  • Kim Blick · STUDY_CHAIR · Zimmer Biomet

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subject qualifies for meniscal repair based on the physical exam and medical history and meets the approved indications for use of the study product;
Older than 18 years and skeletally mature;
Willing and able to comply with the study procedures;
Subject is capable of understanding the doctor's explanations, following his instructions and is able to participate in the follow-up program;
Subject is able to read and understand the informed consent form (ICF) and has voluntarily provided written informed consent.

Exclusion

Meniscal tears in the avascular zone of meniscus;
Meniscal tears not suitable for repair because of the degree of damage(marked irregularity and complex tearing) to the meniscus body including degenerative, radial, horizontal cleavage and flap tears;
Presence of active infection;
If female, subject is pregnant;
Subject is vulnerable (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant);
The subject is unwilling or unable to give consent or to comply with the follow-up program;
Subject meets any contraindications of the appropriate Instruction for Use.
  • Clinical Success1 year

    The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.